Search Result
| 1 |
Solid-phase extraction and validated spectrofluorimetric quantification of pamidronate in human plasma
Abstract |
 Fulltext
|
| 2 |
Development and validation of spectrophotometric and spectrofluorimetric methods for determination of cilnidipine
Abstract |
Fulltext
|
| 3 |
Enhanced spectrofluorimetric determination of the multitargeted tyrosine kinase inhibitor, crizotinib, in human plasma via micelle-mediated approach
Abstract |
Fulltext
|
| 4 |
A new spectrofluorimetric assay method for vandetanib in tablets, plasma and urine
Abstract |
Fulltext
|
| 5 |
A novel method to determine new potent angiotensin inhibitor, azilsartan, in human plasma via micelle-enhanced spectrofluorimetry using cremophor RH 40
Abstract |
Fulltext
|
5 matching items found
|
Archives
| 2025; 24: |
1,
2,
3.
|
| 2024; 23: |
1,
2,
3,
4,
5,
6,
7,
8,
9,
10,
11,
12.
|
| 2023; 22: |
1,
2,
3,
4,
5,
6,
7,
8,
9,
10,
11,
12.
|
| 2022; 21: |
1,
2,
3,
4,
5,
6,
7,
8,
9,
10,
11,
12.
|
| 2021; 20: |
1,
2,
3,
4,
5,
6,
7,
8,
9,
10,
11,
12.
|
| 2020; 19: |
1,
2,
3,
4,
5,
6,
7,
8,
9,
10,
11,
12.
|
| 2019; 18: |
1,
2,
3,
4,
5,
6,
7,
8,
9,
10,
11,
12.
|
| 2018; 17: |
1,
2,
3,
4,
5,
6,
7,
8,
9,
10,
11,
12.
|
| 2017; 16: |
1,
2,
3,
4,
5,
6,
7,
8,
9,
10,
11,
12.
|
| 2016; 15: |
1,
2,
3,
4,
5,
6,
7,
8,
9,
10,
11,
12.
|
| 2015; 14: |
1,
2,
3,
4,
5,
6,
7,
8,
9,
10,
11,
12.
|
| 2014; 13: |
1,
2,
3,
4,
5,
6,
7,
8,
9,
10,
11,
12.
|
| 2013; 12: |
1,
2,
3,
4,
5,
6.
|
| 2012; 11: |
1,
2,
3,
4,
5,
6.
|
| 2011; 10: |
1,
2,
3,
4,
5,
6.
|
| 2010; 9: |
1,
2,
3,
4,
5,
6.
|
| 2009; 8: |
1,
2,
3,
4,
5,
6.
|
| 2008; 7: |
1,
2,
3,
4.
|
| 2007; 6: |
1,
2,
3,
4.
|
| 2006; 5: |
1,
2.
|
| 2005; 4: |
1,
2.
|
| 2004; 3: |
1.
|
| 2003; 2: |
1,
2.
|
| 2002; 1: |
1,
2.
|
|
